Novel pyridazinone derivatives as inhibitors of cdk2

C - Chemistry – Metallurgy – 07 – D

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07D 401/14 (2006.01) A61K 31/501 (2006.01) A61K 31/5377 (2006.01) A61P 35/00 (2006.01) C07D 413/04 (2006.01)

Patent

CA 2567154

The present invention relates to compounds according to the general formula (I), with the definitions of the substituents X, R1 and R2 given below in the text, as well as their physiologically acceptable salts, methods for producing these compounds and their use as pharmaceuticals. These compounds are kinase inhibitors, in particular inhibitors of the kinase CDK2 (cyclin-dependent kinase 2).

L'invention a trait à des composés représentés par la formule générale (I), les substituants X, R?1¿ et R?2¿ étant définis dans le descriptif, et à leurs sels physiologiquement acceptables, à des procédés de production de ces composés et à leur utilisation comme agents pharmaceutiques. Ces composés constituent des inhibiteurs de kinase, en particulier des inhibiteurs de la kinase CDK2 (kinase 2 dépendant des cyclines).

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Novel pyridazinone derivatives as inhibitors of cdk2 does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Novel pyridazinone derivatives as inhibitors of cdk2, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Novel pyridazinone derivatives as inhibitors of cdk2 will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1707608

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.